UVA researchers warn GLP-1 drugs may not provide long-term weight loss benefits

CHARLOTTESVILLE, Va. (WRIC) -- New research from experts at the University of Virginia (UVA) says that GLP-1 drugs may help people lose weight, but do not provide benefits that set the body up for long-term health.

The weight that people lose while on GLP-1 drugs -- which are often used to aid in managing Type 2 diabetes -- includes significant muscle loss. UVA researchers said that muscle is "essential for posture, physical function and overall well-being."

As a result, the recommendation from experts is to complete additional programs including exercise routines, nutrition supplements or complementary medications to ensure that the individuals losing weight on these drugs are also being provided with long-lasting health benefits.

While reviewing previous studies, UVA researchers found that GLP-1 drugs do help improve aspects of heart function, but may negatively impact the body's general ability to exercise, which is important for sustaining health benefits related to weight loss.

For more information, and to read the full release from UVA Health, click here.